Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 13;52(1):826.
doi: 10.1007/s11033-025-10909-1.

Potential role of pentraxin 3 (PTX3) and aldehyde dehydrogenase (ALDH) in liver cirrhotic patients: predicting and diagnostic impact in hepatocellular carcinoma (HCC) development

Hoda M El-Emshaty  1 , Elsaid Ali Eladle  1 , Mohamed Abdel-Wahab  1 , Salma M Khirallah  2
Affiliations

Potential role of pentraxin 3 (PTX3) and aldehyde dehydrogenase (ALDH) in liver cirrhotic patients: predicting and diagnostic impact in hepatocellular carcinoma (HCC) development

Hoda M El-Emshaty et al. Mol Biol Rep. .

Abstract

Background and objective: Patients with liver cirrhosis (LC) are at the highest risk of developing hepatocellular carcinoma (HCC). Thus, this research aimed to clarify the tumorigenic potential of PTX3 and ALDH implicated in HCC development and to find a novel diagnostic model for predicting HCC earlier in liver cirrhotic Egyptian patients.

Patients and methods: 88 patients hospitalized at Gastrointestinal Surgery Center for liver transplantation; 63 HCV-chronic liver disease patients after successful Direct acting antiviral (DAA) therapy (30 HCC patients on top of LC and 33 LC patients) and 25 Non-viral LC in addition to 25 healthy individuals. PTX3 and ALDH serum levels were estimated by Enzyme linked immunosorbent assay (ELISA).

Results: PTX3, ALDH and AFP were significantly correlated with each other and its higher expression was associated with tumor differentiation and inflammatory markers in HCC patients and with LC activity in HCV-LC. Regression analysis of PTX3, ALDH, AFP and the inflammatory markers (PLR, NLR, AAR, Pt) evidenced substantial prediction for tumor grading, Child score, and LC activity as independent predictors for disease severity and tumor progression. Composite score of PTX3 + AFP + FIB4 exhibit higher diagnostic accuracy for discriminating HCC from LC patients with AUROC (0.872), sensitivity (90%), specificity (87.8%) and Accuracy (88.9%).

Conclusions: Inflammation and tissue injury might provoke the tumorigenic potential of PTX3 and ALDH in HCV chronic liver diseases foremost HCC development even after successful eradication for HCV. Diagnostic model (PTX3 + AFP + FIB4) showed the best diagnostic accuracy for discriminating HCC from LC patients.

Keywords: ALDH; HCC; HCV-chronic liver diseases; LC; Pentraxin-3.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study design was approved by the ethics committee of the Faculty of Science - Port Said University - Egypt (ERN: PSU. Sci. 4) in accordance with the ethical standards of the Helsini Declaration. Before the trial protocol started, each participant in this investigation gave written informed consent. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

References

    1. Fadlallah H, Masri DE, Bahmad HF, Abou-Kheir W, Masri JE (2025) Update on the complications and management of liver cirrhosis. Med Sci 13:1–29. https://doi.org/10.3390/medsci13010013 - DOI
    1. Younossi Z, Papatheodoridis G, Cacoub P, Negro F, Wedemeyer H, Henry L, Hatzakis A (2018) The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease. J Viral Hepat 25 Suppl 36–14. https://doi.org/10.1111/jvh.13005
    1. Konstantinov D, Popova L, Konstantinova E (2016) Hepatocellular carcinoma in patients with chronic hepatitis C. Int J Biomed 6:195–198. https://doi.org/10.21103/article6(3)_oa7 - DOI
    1. Vesterhus M, Nielsen MJ, Hov JR, Saffioti F, Manon-Jensen T, Leeming DJ, Moum B, Boberg KM, Pinzani M, Karlsen TH, Karsdal MA, Thorburn D (2021) Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease. JHEP Rep 3. https://doi.org/10.1016/j.jhepr.2020.100178
    1. Tinkle CL, Haas-Kogan D (2012) Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics 6:207–219. https://doi.org/10.2147/BTT.S23907 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources